Ping Chi, MD, PHD Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center Dr. Ping Chi is an Assistant Member in the Human Oncology and Pathogenesis Program (HOPP) and an Attending Physician in the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSKCC). Dr. Chi earned her MD/PhD degree from the Weill Cornell/Rockefeller University/MSKCC tri-institutional MD/PhD program. She completed her clinical training in internal medicine at the Brigham and Women’s Hospital and Medical Oncology Fellowship at MSKCC, as well as a concurrent postdoctoral training in epigenetics and chromatin biology in the C. David Allis’ lab at the Rockefeller University. She maintains an active academic clinical practice, leads early phase clinical trials, and works with a multidisciplinary team to care for patients with melanoma and sarcomas with the goal to expedite clinical translation of laboratory research. Dr. Chi’s laboratory research focuses on understanding the genetic and epigenetic mechanisms of transcriptional activation of novel oncogenic transcripts and oncogenic transcription factors in solid tumor malignancies. Through mechanistic studies, she aims to identify novel therapeutic strategies to target oncogenic transcription factors and aberrant transcriptional activation of oncogenes.